Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant

Osteoporosis International

Volumn 22, Issue 1, 2011, Pages 281-287

  Torregrosa, J V ^a   Fuster, D ^a   Monegal, A ^a   Gentil, M A ^b   Bravo, J ^c   Guirado, L ^d   Muxi A ^a   Cubero, J ^e  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d FUNDACIÓ PUIGVERT   (Spain)

^e HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Bisphosphonates; Bone mass loss; Kidney transplantation; Pamidronate

Indexed keywords

BASILIXIMAB; CALCITRIOL; CALCIUM; COLECALCIFEROL; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PAMIDRONIC ACID; PLACEBO; POLYCLONAL ANTIBODY; PREDNISONE; VITAMIN D;

ADULT; ARTICLE; BONE MASS; BONE PAIN; BONE REMODELING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FRACTURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LUMBAR SPINE; MALE; MULTICENTER STUDY; OSTEOPENIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; BONE REMODELING; CREATININE; DIPHOSPHONATES; EPIDEMIOLOGIC METHODS; FEMALE; FEMUR; FEMUR NECK; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY TRANSPLANTATION; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; POSTOPERATIVE CARE; TREATMENT OUTCOME;

EID: 78651517470     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1197-2     Document Type: Article

References (17)

1. BP Lukert LG Raisz 1990 Corticosteroid-induced osteoporosis: pathogenesis and management Ann Intern Med 112 352 364 1:CAS:528:DyaK3cXktlCktrs%3D 2407167
2. SL Fan MK Almond E Ball K Evans J Cunningham 2000 Pamidronate therapy as prevention of bone loss following renal transplantation Kidney Int 57 684 690 1:CAS:528:DC%2BD3cXktFCqtr4%3D 10652047
3. M Coco D Glicklich MC Faugere, et al. 2003 Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate J Am Soc Nephrol 14 2669 2676 1:CAS:528:DC%2BD3sXnt1aht7o%3D 10.1097/01.ASN.0000087092.53894.80 14514747
4. GA Rodan HA Fleisch 1996 Bisphosphonates: mechanisms of action J Clin Invest 97 2692 2696 1:CAS:528:DyaK28XjvVWksrw%3D 10.1172/JCI118722 8675678
5. E Shane V Addesso PB Namerow, et al. 2004 Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation N Engl J Med 350 767 776 1:CAS:528:DC%2BD2cXhsVems74%3D 10.1056/NEJMoa035617 14973216
6. T Bianda A Linka G Junga, et al. 2000 Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate Calcif Tissue Int 67 116 121 1:CAS:528:DC%2BD3cXmtFCjtro%3D 10.1007/s00223001126 10920215
7. K/DOQI 2002 Clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification Am J Kidney Dis 39 S1 S266 10.1016/S0272-6386(02)70081-4
8. European best practice guidelines for renal transplantation 2002 Section IV: long-term management of the transplant recipient Nephrol Dial Transplant 17 Suppl 4 20 21
9. SB Walsh P Altmann J Pattison, et al. 2009 Effect of pamidronate on bone loss after kidney transplantation: a randomized trial Am J Kidney Dis 53 856 865 1:CAS:528:DC%2BD1MXlvFOjs74%3D 10.1053/j.ajkd.2008.11.036 19393473
10. RM Aris GE Lester JB Renner, et al. 2000 Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation Am J Respir Crit Care Med 162 941 946 1:STN:280:DC%2BD3cvotFalsA%3D%3D 10988110
11. M Ninkovik SJ Skingle PW Bearcroft N Bishop GJ Alexander JE Compston 2000 Incidence of vertebral fractures in the first three months after orthopic liver transplantation Eur J Gastroenterol Hepatol 12 931 935 10.1097/00042737- 200012080-00013
12. W Grotz C Nagel D Poeschel, et al. 2001 Effect of ibandronate on bone loss and renal function after kidney transplantation J Am Soc Nephrol 12 1530 1537 1:CAS:528:DC%2BD3MXltlSiu7k%3D 11423583
13. M Haas Z Leko-Mohr P Roschger, et al. 2003 Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation Kidney Int 63 1130 1136 1:CAS:528:DC%2BD3sXivV2jtrc%3D 10.1046/j.1523-1755.2003.00816.x 12631097
14. C Schwartz C Mitterbauer G Heinze W Woloszczuk M Haas R Oberbauer 2004 Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation Kidney Int 65 304 309 10.1111/j.1523-1755. 2004.00369.x
15. E Shane MA Rodino DJ McMahon, et al. 1998 Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study J Heart Lung Transplant 17 1089 1096 1:STN:280:DyaK1M%2FntFSqsg%3D%3D 9855448
16. HL Reeves RM Francis DM Manas M Hudson CP Day 1998 Intravenous bisphosphonate prevents symptomatic osteoporosis vertebral collapse in patients after liver transplantation Liver Transplant Surg 4 404 409 1:STN:280: DyaK1czptFyisg%3D%3D 10.1002/lt.500040508
17. SC Palmer DO McGregor GF Strippoli 2007 Interventions for preventing bone disease in kidney transplant recipients Cochrane Database Syst Rev 3 CD005015 17636784